Literature DB >> 22694120

Risk factors for native kidney dysfunction in patients with abdominal multivisceral/small bowel transplantation.

M Suzuki1, M A Mujtaba, A A Sharfuddin, M S Yaqub, D P Mishler, S Faiz, R M Vianna, R S Mangus, J A Tector, T E Taber.   

Abstract

Kidney dysfunction is a recognized complication after non-renal solid organ transplantation, particularly after intestinal transplant. In our study, we reviewed data on 33 multivisceral transplant (MVT)- and 15 isolated small bowel (ISB)-transplant patients to determine risk factors for kidney dysfunction. Kidney function was estimated by modified diet in renal disease (MDRD) and Schwartz formula for adults and children, respectively. Acute kidney injury (AKI) was defined as an increase in the serum Cr (sCr) greater than twofold. Kidney function declined significantly at one yr after transplantation with 46% of subjects showing an estimated GFR (eGFR) <60 mL/min. Patients with an episode of AKI were more likely to have reduced eGFR than those without AKI (p < 0.025). In linear regression analyses, age, pre-transplant sCr, eGFR at postoperative day (POD) 30, 90, 180, 270, and tacrolimus level at POD 7 showed significant correlation with one yr post-transplant eGFR (p < 0.05). Pediatric patients and patients with MVT had lesser decline in kidney function compared with adults or patients with ISB. In conclusion, risk factors for post-transplant kidney dysfunction in intestinal transplantation included age, pre-transplant sCr, AKI episode, eGFR at POD 30, 90, 180, 270, and tacrolimus level at POD 7.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22694120     DOI: 10.1111/j.1399-0012.2012.01672.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  5 in total

1.  End-stage kidney disease after pediatric nonrenal solid organ transplantation.

Authors:  Rebecca L Ruebner; Peter P Reese; Michelle R Denburg; Peter L Abt; Susan L Furth
Journal:  Pediatrics       Date:  2013-10-14       Impact factor: 7.124

2.  The use of renal replacement therapy in critically ill pediatric small bowel transplantation candidates and recipients: Experience from one center.

Authors:  Carol Pineda; Tristan Grogan; James A Lin; Joshua J Zaritsky; Robert Venick; Douglas G Farmer; Robert B Kelly
Journal:  Pediatr Transplant       Date:  2015-03-26

3.  Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center.

Authors:  Ibtesam A Hilmi; Raymond M Planinsic; Ramona Nicolau-Raducu; Daniela Damian; Ali Al-Khafaji; Tetsuro Sakai; Kareem Abu-Elmagd
Journal:  World J Transplant       Date:  2013-12-24

4.  Mesenchymal stem cell therapy in patients with small bowel transplantation: single center experience.

Authors:  Sait Murat Doğan; Selçuk Kılınç; Eyüp Kebapçı; Cem Tuğmen; Alp Gürkan; Maşallah Baran; Yusuf Kurtulmuş; Mustafa Olmez; Cezmi Karaca
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 5.  Management of intestinal failure in inflammatory bowel disease: small intestinal transplantation or home parenteral nutrition?

Authors:  Elizabeth Harrison; Philip Allan; Amrutha Ramu; Anil Vaidya; Simon Travis; Simon Lal
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.